Novo Nordisk A/S ADR (NVO)

Mar 31, 2025, 2:34 PM EDT - 5 hours ago

Biotech Stocks Q1 2025 Recap: Winners And Underperformers

CMRX CRVO CVS GERN LLY SEPN

Mar 31, 2025, 2:30 PM EDT - 5 hours ago

Pharma tariffs the 'number one question' on investors' minds, Barclays says

AZN GSK NVS

Mar 30, 2025, 10:37 AM EDT - 1 day ago

Novo Nordisk: Finally A Buying Opportunity

Mar 30, 2025, 5:00 AM EDT - 1 day ago

Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors

LLY

Mar 29, 2025, 2:33 PM EDT - 2 days ago

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025

Mar 29, 2025, 2:30 PM EDT - 2 days ago

Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years

Mar 28, 2025, 6:21 PM EDT - 3 days ago

GLP-1 space will remain two player over the medium to long term, says Mizuho's Jared Holz

LLY

Mar 28, 2025, 10:09 AM EDT - 3 days ago

Lexicon Pharmaceuticals Shares Soar on Novo Nordisk Licensing Deal

LXRX

Mar 28, 2025, 9:41 AM EDT - 3 days ago

Novo Nordisk says compounded drugs are hurting Wegovy sales

Mar 28, 2025, 9:37 AM EDT - 3 days ago

Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'

Mar 28, 2025, 9:02 AM EDT - 3 days ago

Penny Stock Lexicon Pharmaceuticals Surges On Obesity Pact Worth $1 Billion With Novo Nordisk

LXRX

Mar 28, 2025, 8:41 AM EDT - 3 days ago

BoFA says Novo Nordisk may miss Q1 expectations as Wegovy, Ozempic sales lag

Mar 28, 2025, 7:41 AM EDT - 3 days ago

Lexicon to license obesity drug to Novo Nordisk in up to $1 billion deal

Mar 27, 2025, 1:46 PM EDT - 4 days ago

Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action

Mar 27, 2025, 1:29 PM EDT - 4 days ago

Novo shares on track for biggest monthly fall since 2002, investor worries grow

Mar 27, 2025, 11:17 AM EDT - 4 days ago

Resolutions from the Annual General Meeting of Novo Nordisk A/S

Mar 26, 2025, 5:58 PM EDT - 5 days ago

Checking in on the weight-loss drug space: Novo Nordisk, Eli Lilly, and others

LLY

Mar 26, 2025, 2:01 PM EDT - 5 days ago

Novo Nordisk Stock Sinks To 52-Week Lows: Weight Loss Boom Losing Steam?

Mar 26, 2025, 7:30 AM EDT - 5 days ago

Buy Low, Never Sell - 2 Elite Dividend Stocks Built To Last

ENB

Mar 25, 2025, 12:59 PM EDT - 6 days ago

Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly

Mar 24, 2025, 1:23 PM EDT - 7 days ago

SAP Overtakes Novo Nordisk as Europe's Most Valuable Company

SAP

Mar 24, 2025, 11:23 AM EDT - 7 days ago

Novo Nordisk's $2 billion obesity deal

LLY

Mar 24, 2025, 8:07 AM EDT - 7 days ago

Novo Nordisk expands discounted Wegovy to all cash-paying US customers

Mar 24, 2025, 8:00 AM EDT - 7 days ago

Novo Nordisk expands Wegovy® $499-per-month offering to additional cash-paying patients via the Wegovy® savings offer

Mar 24, 2025, 6:21 AM EDT - 7 days ago

Novo Nordisk secures license to weight-loss drug candidate from China's United Labs

Mar 24, 2025, 6:02 AM EDT - 7 days ago

The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist

Mar 24, 2025, 5:20 AM EDT - 7 days ago

Germany's SAP overtakes Novo Nordisk as Europe's largest company

SAP

Mar 24, 2025, 2:36 AM EDT - 7 days ago

Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure

Mar 17, 2025, 2:48 PM EDT - 14 days ago

UK Pharma Industry Trade Association Restores Wegovy/Ozempic Maker Novo Nordisk's Membership After 2 Years Of Suspension

Mar 17, 2025, 11:17 AM EDT - 14 days ago

Novo Nordisk membership in UK pharma body restored after suspension

Mar 15, 2025, 9:12 AM EDT - 16 days ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Mar 14, 2025, 6:08 PM EDT - 17 days ago

Drugmakers agree to participate in second round of price negotiations

ABBV AZN GSK MRK TEVA

Mar 14, 2025, 9:00 AM EDT - 17 days ago

Novo Nordisk: Stock Plunges, But It May Be Time To Load Up

Mar 13, 2025, 10:31 AM EDT - 18 days ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Mar 13, 2025, 5:45 AM EDT - 18 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Novo Nordisk A/S Lawsuit - NVO

Mar 12, 2025, 6:23 PM EDT - 19 days ago

Novo Nordisk sell-off is completely overdone, says Mizuho's Jared Holz

Mar 12, 2025, 6:22 PM EDT - 19 days ago

Final Trade: AAPL, NVO, ADBE, FCX

AAPL ADBE FCX

Mar 12, 2025, 6:23 AM EDT - 19 days ago

How a Novo Nordisk Foundation-funded project sparked ultra-processed food fight